Arterial Revascularization Therapies Study II: Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions - ARTS II: 5-Year Results


The goal of the trial was to evaluate in a nonrandomized, open-label study, treatment with sirolimus-eluting stents (SES) compared with historical controls in the ARTS I trial of patients undergoing revascularization with coronary artery bypass graft surgery (CABG) or bare-metal stents (BMS) in patients with multivessel disease.